Literature DB >> 23702008

Transcatheter device closure of atrial septal defects: a safety review.

John Moore1, Sanjeet Hegde, Howaida El-Said, Robert Beekman, Lee Benson, Lisa Bergersen, Ralf Holzer, Kathy Jenkins, Richard Ringel, Jonathan Rome, Robert Vincent, Gerard Martin.   

Abstract

This review discusses the current safety issues related to U.S. Food and Drug Administration approved atrial septal defect devices and proposes a potential avenue to gather additional safety data including factors, which may be involved in device erosion.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23702008     DOI： 10.1016/j.jcin.2013.02.005

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


  48 in total

1.  Comparison of Figulla Flex® and Amplatzer™ devices for atrial septal defect closure: A meta-analysis.

Authors:  Alvaro Aparisi; Roman J Arnold; Hipólito Gutiérrez; Ana Revilla; Ana Serrador; Benigno Ramos; Tania Rodriguez-Gabella; Alberto Campo; Carlos Baladrón; Itziar Gómez; Manuel Carrasco-Moraleja; José A San Roman; Ignacio J Amat-Santos
Journal:  Cardiol J       Date:  2020-04-24       Impact factor: 2.737

Review 2.  Three-dimensional transesophageal echocardiography of atrial septal defect device closure.

Authors:  David A Roberson; Vivian Wei Cui
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

3.  Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder.

Authors:  Thomas Herren; Michael Schwanda; Michele Genoni; Franz R Eberli
Journal:  Clin Res Cardiol       Date:  2015-02-27       Impact factor: 5.460

4.  Coronary Sinus Defect Following Transcatheter Closure of ASD Using Amplatzer Septal Occluder: Potential Erosion by the Device.

Authors:  Bassel Mohammad Nijres; Maytham Al-Kubaisi; John Bokowski; Ra-Id Abdulla; Sawsan Awad
Journal:  Pediatr Cardiol       Date:  2017-04-10       Impact factor: 1.655

Review 5.  Strategies for Recovering an Embolized Percutaneous Device.

Authors:  Thomas Nestelberger; Mesfer Alfadhel; Cameron McAlister; Rohit Samuel; Jacqueline Saw
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

6.  Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years.

Authors:  Jan-Erik Guelker; Ruben Jansen; Kolja Sievert; Horst Sievert; Stefan Bertog
Journal:  Clin Res Cardiol       Date:  2018-02-26       Impact factor: 5.460

Review 7.  State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.

Authors:  Michael L O'Byrne; Daniel S Levi
Journal:  Interv Cardiol Clin       Date:  2019-01

8.  Late Cardiac Rupture after Amplatzer Septal Occluder Implantation.

Authors:  Ahmet Arnaz; Yasemin Turkekul; Yusuf Yalcinbas; Arda Saygili; Tayyar Sarioglu
Journal:  Tex Heart Inst J       Date:  2016-12-01

9.  Percutaneous retrieval and redeployment of an atrial septal occluder under three-dimensional transesophageal echocardiographic guidance: a case report.

Authors:  Jinhee Ahn; Jin Hee Kim; Jung Hyun Choi; Jun-Hyok Oh
Journal:  J Korean Med Sci       Date:  2014-05-30       Impact factor: 2.153

10.  Anatomical Substrates and Ablation of Reentrant Atrial and Ventricular Tachycardias in Repaired Congenital Heart Disease.

Authors:  Charlotte Brouwer; Mark G Hazekamp; Katja Zeppenfeld
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.